Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 2,465,800 | 2,464,900 | 2,290,500 | 2,386,300 | 2,530,300 |
| Cost of Goods | 638,700 | 546,000 | 542,200 | 618,300 | 659,600 |
| Gross Profit | 1,827,100 | 1,918,900 | 1,748,300 | 1,768,000 | 1,870,700 |
| Operating Expenses | 1,362,000 | 1,135,000 | 1,190,000 | 1,409,400 | 1,712,500 |
| Operating Income | 465,800 | 783,900 | 558,500 | 358,900 | 158,800 |
| Other Income | -14,800 | -85,200 | -93,700 | -67,300 | -300,000 |
| Pre-tax Income | 451,000 | 698,700 | 464,800 | 291,600 | -141,200 |
| Income Tax | 62,500 | 115,100 | 71,400 | 42,700 | -72,900 |
| Net Income Continuous | 388,500 | 583,600 | 393,400 | 248,900 | -68,300 |
| Minority Interests | N/A | N/A | N/A | -800 | -200 |
| Net Income | $388,500 | $583,600 | $393,400 | $249,700 | $-68,100 |
| EPS Basic Total Ops | 2.67 | 4.01 | 2.71 | 1.71 | -0.47 |
| EPS Basic Continuous Ops | 2.67 | 4.01 | 2.71 | 1.71 | -0.47 |
| EPS Diluted Total Ops | 2.66 | 4.00 | 2.70 | 1.70 | -0.47 |
| EPS Diluted Continuous Ops | 2.66 | 4.00 | 2.70 | 1.70 | -0.47 |
| EPS Diluted Before Non-Recurring Items | N/A | 5.28 | 3.67 | 2.95 | 4.36 |
| EBITDA(a) | $719,700 | $1,032,900 | $750,100 | $530,500 | $283,800 |